Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2019 for Novelion Therapeutics Inc., €125. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Roger Louis: trading record in brief
Roger Louis is a declared insider of Novelion Therapeutics Inc., with filings sourced from SEDI. We count 7 filings; the first trade dates from 29 November 2016 and the latest from 9 May 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 14 May 2019: a transaction of €125, in Novelion Therapeutics Inc. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Roger Louis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
155 shares@ CA$1.226.1% of flowCommon SharesTSXSEDI:3366998
546 shares@ CA$1.2221.6% of flowCommon SharesTSXSEDI:3366995
161 shares@ CA$4.2622.1% of flowCommon SharesTSXSEDI:3182177
547 sharesCommon SharesTSXSEDI:3182175
162 shares@ CA$9.42100.0% of flowCommon SharesTSXSEDI:3006424
Common SharesTSXSEDI:3006422
547 sharesCommon SharesTSXSEDI:3006423
7 of 7 declarations
